Everence Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,090
| Closed | -$564 | – | 760 |
|
|
2024
Q2 | $564 | Buy |
2,090
+470
| +29% | +$127 | 0.04% | 353 |
|
|
2024
Q1 | $560 | Hold |
1,620
| – | – | 0.04% | 374 |
|
|
2023
Q4 | $523K | Hold |
1,620
| – | – | 0.04% | 392 |
|
|
2023
Q3 | $581 | Buy |
1,620
+900
| +125% | +$323 | 0.05% | 340 |
|
|
2023
Q2 | $269K | Hold |
720
| – | – | 0.02% | 562 |
|
|
2023
Q1 | $345 | Hold |
720
| – | – | 0.03% | 486 |
|
|
2022
Q4 | $303 | Buy |
720
+110
| +18% | +$46 | 0.03% | 537 |
|
|
2022
Q3 | $254K | Sell |
610
-70
| -10% | -$29.1K | 0.02% | 574 |
|
|
2022
Q2 | $337K | Buy |
+680
| New | +$337K | 0.03% | 473 |
|
|
2022
Q1 | – | Sell |
-580
| Closed | -$438K | – | 736 |
|
|
2021
Q4 | $438K | Sell |
580
-420
| -42% | -$317K | 0.03% | 467 |
|
|
2021
Q3 | $746K | Hold |
1,000
| – | – | 0.06% | 258 |
|
|
2021
Q2 | $644K | Hold |
1,000
| – | – | 0.05% | 315 |
|
|
2021
Q1 | $571K | Hold |
1,000
| – | – | 0.05% | 323 |
|
|
2020
Q4 | $583K | Buy |
1,000
+500
| +100% | +$292K | 0.06% | 298 |
|
|
2020
Q3 | $258K | Buy |
+500
| New | +$258K | 0.03% | 511 |
|